Pilot study to determine the efficacy and safety of Glivec (STI571) alone and Glivec (STI571) plus Intron A in the early recovery phase post autologous blood or marrow transplant for advanced phase chronic myeloid leukaemia and Ph-positive acute lymphoblastic leukemia.
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Imatinib (Primary) ; Interferon alpha-2b (Primary)
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
Most Recent Events
- 30 Aug 2011 New trial record